SRPT vs VSTD
Sarepta Therapeutics Inc (SRPT) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
SRPT currently screens at market cap $2.34B. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the SRPT and VSTD stock pages for the full models.
Not investment advice.